Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global protein expression market was valued at USD 3.16 Billion in 2025. It is poised to grow at a CAGR of 5.40% during the forecast period of 2026-2035, and reach USD 5.35 Billion by 2035. The market growth is driven by the rising demand for biologics, increasing prevalence of chronic diseases, and transformative technological advancements in expression systems.
As reported by MIT News, researchers launched OpenProtein.AI, an open platform that brings advanced AI-driven protein design tools to a broader scientific community. The tools accelerate engineering of novel enzymes, antibodies, and therapeutic proteins, supporting strong upstream demand for cell-free expression systems, mammalian and microbial production platforms, and high-throughput screening reagents across biopharmaceutical and academic research markets.
According to research summarized by the U.S. National Institutes of Health, cell-free protein expression continues to gain traction as a flexible alternative to traditional cell-based biomanufacturing for complex, toxic, and post-translationally modified proteins. Strategic partnerships and licensing agreements are intensifying among reagent suppliers and biopharmaceutical developers, supporting accelerating revenue growth across cell-free expression kits, lysates, and on-demand protein production platforms.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
5.4%
Value in USD Billion
2026-2035
*this image is indicative*
Protein expression is the biological and biotechnological process by which genetic information from DNA is converted into functional proteins. In a natural context, it is a key component of gene expression, encompassing transcription of DNA into messenger RNA (mRNA), subsequent translation into amino acids, and finally folding into a functional 3D structure. The market is fueled by the pharmaceutical industry’s aggressive shift toward biologics and precision medicine. The market was valued at USD 3.16 Billion in 2025. The growth is further supported by the surge in high-value drug development.
Rising Integration of AI-Driven Protein Analytics to Enhance the Market Value
The increasing integration of artificial intelligence in protein analysis is significantly driving market growth by improving the accuracy and efficiency of protein expression studies. In July 2025, researchers from Poznan University of Medical Sciences and the University of São Paulo developed PROTsi, an AI-based model that analyzes protein expression to predict tumor aggressiveness and identify therapeutic targets. This advancement supports biomarker-based treatment, patient stratification, and drug response prediction, thereby strengthening the role of protein expression technologies and accelerating overall market growth.
Some notable trends in the market include the expanding adoption of cell-free protein expression technologies.
Growing Expansion of Cell-Free Protein Expression Technologies is Likely to Accelerate Market Growth
The market is witnessing a growing shift toward advanced cell-free protein expression platforms that enable rapid and efficient synthesis of complex proteins. In April 2025, LenioBio partnered with Avantor to expand the accessibility of its ALiCE® technology across Europe, enhancing research capabilities and reducing dependency on traditional cell-based systems. This trend is expected to streamline protein production workflows and significantly support overall market growth.
Market Breakup by Type of Expression System
Market Breakup by Product Type
Market Breakup by Application
Market Breakup by Technique
Market Breakup by Cell Type
Market Breakup by End User
Market Breakup by Region
Mammalian Expression Systems to Dominate Market Segmentation by Type
The mammalian expression systems are likely to hold a significant share in the market Among all the types by offering an unrivaled capacity for complex post-translational modifications (PTMs). This segment holds capacity, such as glycosylation and proper folding, which are critical for the biological activity and safety of modern therapeutics. As financial risk-aversion drives investment toward established, regulatory-proven technologies like CHO cells, the sector continues to grow despite higher operational costs, offering a lower "certainty premium" over faster but less complex alternatives.
The regions included in the market are North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Among these, North America continues anticipated to hold a substantial market share. This supremacy is driven by robust biopharmaceutical infrastructure and substantial R&D investments from organizations like the NIH. From a macroeconomic perspective, the region's concentration of liquid capital and high-tier academic centers creates a fertile environment for innovation, even amidst fluctuating interest rates. Recently, the FDA's expedited approval timelines and a surge in mammalian-based biologic production have further solidified this leadership. This growth trajectory is sustained by relentless technological advancements, such as AI-driven protein design platforms.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Thermo Fisher Scientific, Inc. is the dominant leader in the market due to its high-growth segments like cell-free protein expression. The company provides a vertically integrated ecosystem that spans from early-stage gene synthesis and cloning to large-scale commercial manufacturing through its specialized brands like Invitrogen, Gibco, and Patheon.
Merck KGaA (Sigma-Aldrich Corporation) is a primary leader in the market, ranked as a top-tier provider. The company’s Life Science business sector, provides a comprehensive end-to-end ecosystem for protein research, from gene cloning to industrial-scale bioprocessing.
Agilent Technologies, Inc. is a major global player in the protein expression market, positioning itself as a leader in high-performance analytical tools, reagents, and end-to-end biopharma solutions. Unlike competitors who focus heavily on high-volume media, Agilent’s market strength lies in solving complex expression challenges, such as protein insolubility and codon bias, through specialized host cells and advanced characterization instruments.
Bio-Rad Laboratories, Inc. is a vital "enabler" in the market, specializing in the specialized instrumentation and reagents essential for the separation, purification, and analysis of expressed proteins. The company is the industry standard for the downstream workflow, particularly in electrophoresis and chromatography.
Other key players in the market are QIAGEN N.V., Lonza Group AG, GenScript Biotech Corporation, Takara Bio Inc., Promega Corporation, New England Biolabs, Oxford Expression Technologies Ltd. (OET), Synthetic Genomics, Inc., Biomatik Corporation, Cayman Chemical Company, Zymo Research Corporation.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type of Expression System |
|
| Breakup by Product Type |
|
| Breakup by Application |
|
| Breakup by Technique |
|
| Breakup by Cell Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share